Tumor News and Research

RSS

UC Davis professor wins NIH award to develop ‘smart’ immune cells for cancer therapies

Assistant Professor Sean Collins, Department of Microbiology and Molecular Genetics in the UC Davis College of Biological Sciences, has received a $1.5 million award from the National Institutes of Health to advance the development of "smart" immune cells for therapies to treat cancer and other diseases.

6 Oct 2017

CRI scientists challenge oldest concept in tumor metabolism

Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) have discovered that lactate provides a fuel for growing tumors, challenging a nearly century-old observation known as the Warburg effect.

6 Oct 2017

New research can help develop better chemotherapy treatments for pancreatic cancer

Tal Danino, a professor at the Data Science Institute, is conducting research that could help scientists combat the most lethal of cancers: pancreatic cancer.

6 Oct 2017

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Lymphoma is the most common blood cancer, but the diagnosis belies a wildly diverse and little understood genetic foundation for the disease that hampers successful treatment.

5 Oct 2017

Study provides insight into how cells in the body adapt to nerve injury

Genetic processes that allow cells to transform so they can mend damaged nerves have been identified by scientists.

5 Oct 2017

New app helps doctors make better decisions during brain surgeries

A new app developed by the University of Wisconsin-Milwaukee and the Medical College of Wisconsin helps doctors make better decisions during brain surgeries.

5 Oct 2017

Gene targets for triple negative breast cancers resistant to chemotherapy found

Researchers have finally found the genetic targets that could be used for treatment and development of new drugs in patients who are resistant to chemotherapy. These patients who are resistant to chemotherapy are most likely to have triple negative breast cancer which is the most aggressive form of breast cancer. The study appeared in the latest issue of the journal Cell Metabolism.

4 Oct 2017

UAlberta researchers create new imaging agents to keep track of tumor growth

UAlberta researchers have created two new imaging agents that could help physicians visualize the formation of tumor-associated blood vessels, keep track of tumor growth and possibly generate new therapies.

4 Oct 2017

UCLA researchers develop new method to rapidly measure cell's stiffness and size

UCLA biophysicists have developed a new method to rapidly determine a single cell's stiffness and size -- which could ultimately lead to improved treatments for cancer and other diseases.

4 Oct 2017

New radiotherapy technology reduces treatment times with improved accuracy

Patients at UC San Diego Health in need of radiation therapy now have access to the next generation of radiation treatment technology. The new radiotherapy system significantly reduces treatment times with improved accuracy.

3 Oct 2017

Researchers find link between maternal pesticide use and risk of childhood brain tumors

Previous epidemiological studies have suggested that exposure to pesticides during pregnancy may have a possible role in the development of childhood brain tumors.

3 Oct 2017

Research uncovers potential targets for treatment of triple negative breast cancer

Research led by Dr. Carlos Arteaga, Director of the Harold C. Simmons Comprehensive Cancer Center, has identified potential targets for treatment of triple negative breast cancer, the most aggressive form of breast cancer.

3 Oct 2017

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

A team led by Massachusetts General Hospital (MGH) investigators has identified a new cancer-causing pathway behind most cases of an aggressive type of leukemia, findings that could lead to new targeted treatment approaches.

3 Oct 2017

Novel microscopy technique can more accurately diagnose cancer than current methods

A novel microscopy technique to examine tumour tissue in three dimensions can more accurately diagnose cancer than current two-dimensional methods, according to a study conducted at Karolinska Institutet and Karolinska University Hospital in Sweden. The study is published in Nature Biomedical Engineering.

3 Oct 2017

RCSI-led study aims to train next generation of brain cancer researchers

RCSI is leading an international team of scientists on a major research study that aims to train the next generation of brain cancer researchers.

3 Oct 2017

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

A genetic test developed at UPMC proved highly sensitive at determining which pancreatic cysts are most likely to be associated with one of the most aggressive types of pancreatic cancer, UPMC and University of Pittsburgh School of Medicine scientists reported in Gut, the journal of the British Society of Gastroenterology.

3 Oct 2017

Liquid biopsy can reveal response to checkpoint inhibitor-based immunotherapies

In a first-of-its-kind study, University of California San Diego School of Medicine researchers report that a blood sample, or liquid biopsy, can reveal which patients will respond to checkpoint inhibitor-based immunotherapies.

3 Oct 2017

Alterations in circulating tumor DNA associated with response to checkpoint inhibitors

The number of alterations detected in the DNA collected from blood samples (liquid biopsies) of cancer patients treated with immune checkpoint inhibitors was associated with response to the treatment.

3 Oct 2017

Benefits of Biomarkers in Colorectal Cancer Treatment

Biomarkers fall into different categories: diagnostic biomarkers, are used to identify a disease; prognostic biomarkers, help clinicians to determine, for example, whether you're more likely to die or have problems with a disease; and there are some that can be used to inform treatment, to determine whether one therapy would be more successful than another.

2 Oct 2017

Research findings can lead to new treatment for patients with fatal glandular cancer

A new combination of existing drugs has been shown to block the cancer gene behind a fatal form of glandular cancer, adenoid cystic carcinoma. The findings from the Sahlgrenska Academy can lead to new treatment for patients with this disease relatively soon.

28 Sep 2017

Tumor News and Research

UC Davis professor wins NIH award to develop ‘smart’ immune cells for cancer therapies

CRI scientists challenge oldest concept in tumor metabolism

New research can help develop better chemotherapy treatments for pancreatic cancer

Researchers pinpoint genetic drivers of diffuse large B cell lymphoma

Study provides insight into how cells in the body adapt to nerve injury

New app helps doctors make better decisions during brain surgeries

Gene targets for triple negative breast cancers resistant to chemotherapy found

UAlberta researchers create new imaging agents to keep track of tumor growth

UCLA researchers develop new method to rapidly measure cell's stiffness and size

New radiotherapy technology reduces treatment times with improved accuracy

Researchers find link between maternal pesticide use and risk of childhood brain tumors

Research uncovers potential targets for treatment of triple negative breast cancer

Researchers identify new cancer-causing pathway behind most aggressive type of leukemia

Novel microscopy technique can more accurately diagnose cancer than current methods

RCSI-led study aims to train next generation of brain cancer researchers

Rapid, sensitive genetic test successfully detects some aggressive types of pancreatic cancer

Liquid biopsy can reveal response to checkpoint inhibitor-based immunotherapies

Alterations in circulating tumor DNA associated with response to checkpoint inhibitors

Benefits of Biomarkers in Colorectal Cancer Treatment

Research findings can lead to new treatment for patients with fatal glandular cancer

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News